Table: Kobayashi Pharmaceutical -2021 group results

Kobayashi Pharmaceutical

04/02/2022 06:00

Feb 4 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          155.25          150.51         162.00                 
               (+3.1 pct)      (-4.9 pct)     (+4.3 pct)               
  Operating       26.07           25.94          27.00                 
               (+0.5 pct)      (+1.1 pct)     (+3.6 pct)               
  Recurring       28.02           27.73          28.20                 
               (+1.0 pct)      (-0.4 pct)     (+0.7 pct)               
  Net
  Net             19.72           19.21          20.20                 
               (+2.7 pct)      (+0.3 pct)     (+2.5 pct)               
  EPS          252.36 yen      245.71 yen     259.85 yen               
  Ann Div       83.00 yen       77.00 yen      85.00 yen               
  -Q2 Div       37.00 yen       34.00 yen      38.00 yen               
  -Q4 Div       46.00 yen       43.00 yen      47.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T